Sign in
NITO Stock Price, Chart, Stats & News
Nexentis Technologies Inc.
Save
5.87M
Market cap
–
Current P/E
–
Forward P/E
NITO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 63.80% |
Operating margin | -2703.80% |
Pretax margin | -3284.97% |
Net margin | -3187.13% |
Effective tax rate | – |
ROA | -60.27% |
ROE | -113.68% |
D/E | 0.13x |
Interest coverage ratio | -2.80x |
NITO valuation
P/E | – |
P/S | 3.04x |
P/B | 70.24x |
P/CF | -216.16x |
P/FCF | -0.22x |
P/OCF | -216.16x |
PEG | -2.08x |
EV multiple | -1.01x |
About
Nexentis Technologies Inc. develops and operates an AI and data-driven computational biotech platform. It focuses on mitochondrial biology, precision oncology, and inflammatory metabolic diseases. The company biotechnology segment, driven by its proprietary MITOLINE discovery engine and structure-guided virtual screening workflows, is engaged in the discovery and development of small-molecule therapeutics targeting the mitochondrial SLC25 carrier family for resistant cancers and inflammatory metabolic disease indications.
Similar securities
Based on sector and market capitalization
Report issue